BioNTech SE ADR sell zonthiii
Start price
17.11.20
/
50%
€74.64
Target price
17.11.21
€70.00
Performance (%)
2.10%
End price
18.11.20
€76.21
Summary
This prediction ended on 18.11.20 with a price of €76.21. With a performance of 2.10%, the SELL prediction by zonthiii for BioNTech SE ADR was trending in the wrong direction zonthiii has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
BioNTech SE ADR | 7.896% | 7.896% | 243.124% | - |
iShares Core DAX® | -1.611% | 3.135% | 15.880% | 15.652% |
iShares Nasdaq 100 | -0.500% | 0.775% | 20.054% | 32.402% |
iShares Nikkei 225® | -1.483% | 4.610% | 11.154% | -1.568% |
iShares S&P 500 | -0.501% | 1.914% | 21.016% | 37.314% |
According to zonthiii what are the pros and cons of BioNTech SE ADR for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Capable Management
Differentiated customer and product portfolio
Growths faster than the competition
Top 10 in its market
Very Future proof/growth oriented business model
Cons
Low dividend yield expected
negative Cash Flow expected
Significant cyclical dependencies
Comments by zonthiii for this prediction
In the thread Biontech SE diskutieren
Sell mit Kursziel 7,0
Kursziel geändert auf 70,0
Stopped prediction by zonthiii for BioNTech SE ADR
BioNTech SE ADR
Start price
Target price
Perf. (%)
€76.21
18.11.20
18.11.20
€90.00
18.11.21
18.11.21
274.75%
20.08.21
20.08.21
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
BioNTech SE ADR
Start price
Target price
Perf. (%)
€85.01
16.11.20
16.11.20
€85.00
16.11.21
16.11.21
-12.20%
17.11.20
17.11.20
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group